Milani I, Codini M, Guarisco G, Chinucci M, Gaita C, Leonetti F
Int J Mol Sci. 2024; 25(19).
PMID: 39409124
PMC: 11477334.
DOI: 10.3390/ijms251910795.
Hemat Jouy S, Mohan S, Scichilone G, Mostafa A, Mahmoud A
Biomedicines. 2024; 12(9).
PMID: 39335642
PMC: 11428859.
DOI: 10.3390/biomedicines12092129.
Karimian J, Shekarchizadeh-Esfahani P
Clin Nutr Res. 2024; 13(2):130-138.
PMID: 38784852
PMC: 11109928.
DOI: 10.7762/cnr.2024.13.2.130.
Hao M, Lv Y, Liu S, Guo W
Diabetes Metab Syndr Obes. 2024; 17:1957-1971.
PMID: 38737387
PMC: 11086398.
DOI: 10.2147/DMSO.S433649.
Nigro E, Mallardo M, Amicone M, DArco D, Riccio E, Marra M
Genes (Basel). 2024; 15(4).
PMID: 38674417
PMC: 11050174.
DOI: 10.3390/genes15040484.
Adiponectin-to-leptin ratio and incident chronic kidney disease: Sex and body composition-dependent association.
Park H, Park S, Seong Y, Kim H, Choi H, Rhee Y
J Cachexia Sarcopenia Muscle. 2024; 15(4):1298-1308.
PMID: 38632706
PMC: 11294033.
DOI: 10.1002/jcsm.13475.
Hypertension and diabetes, but not leptin and adiponectin, mediate the relationship between body fat and chronic kidney disease.
Lengton R, Dekker F, van Rossum E, De Fijter J, Rosendaal F, Willems van Dijk K
Endocrine. 2024; 85(3):1141-1153.
PMID: 38627329
PMC: 11316711.
DOI: 10.1007/s12020-024-03811-6.
Cardiometabolic comorbidities and complications of obesity and chronic kidney disease (CKD).
Ali M, Parveen S, Williams V, Dons R, Uwaifo G
J Clin Transl Endocrinol. 2024; 36:100341.
PMID: 38616864
PMC: 11015524.
DOI: 10.1016/j.jcte.2024.100341.
Reevaluating Adiponectin's impact on obesity hypertension: a Chinese case-control study.
Wu O, Lu X, Leng J, Zhang X, Liu W, Yang F
BMC Cardiovasc Disord. 2024; 24(1):208.
PMID: 38615012
PMC: 11015577.
DOI: 10.1186/s12872-024-03865-4.
Comprehensive strategy for identifying extracellular vesicle surface proteins as biomarkers for chronic kidney disease.
Garcia N, Gonzalez-King H, Mellergaard M, Nair S, Salomon C, Handberg A
Front Physiol. 2024; 15:1328362.
PMID: 38379702
PMC: 10877036.
DOI: 10.3389/fphys.2024.1328362.
Improved Glycaemic Control and Nephroprotective Effects of Empagliflozin and Paricalcitol Co-Therapy in Mice with Type 2 Diabetes Mellitus.
Mujalli A, Farrash W, Obaid A, Khan A, Almaimani R, Idris S
Int J Mol Sci. 2023; 24(24).
PMID: 38139208
PMC: 10743534.
DOI: 10.3390/ijms242417380.
Sex differences in obesity-induced renal lipid accumulation revealed by lipidomics: a role of adiponectin/AMPK axis.
Juszczak F, Pierre L, Decarnoncle M, Jadot I, Martin B, Botton O
Biol Sex Differ. 2023; 14(1):63.
PMID: 37770988
PMC: 10537536.
DOI: 10.1186/s13293-023-00543-6.
Obesity-Related Kidney Disease: Current Understanding and Future Perspectives.
Kreiner F, Schytz P, Heerspink H, von Scholten B, Idorn T
Biomedicines. 2023; 11(9).
PMID: 37760939
PMC: 10526045.
DOI: 10.3390/biomedicines11092498.
Fecal and Urinary Adipokines as Disease Biomarkers.
Tews H, Elger T, Grewal T, Weidlich S, Vitali F, Buechler C
Biomedicines. 2023; 11(4).
PMID: 37189804
PMC: 10135691.
DOI: 10.3390/biomedicines11041186.
Effect of Renal Denervation on the Plasma Adiponectin Concentration in Patients with Resistant Hypertension.
Czerwienska B, Lelek M, Gojowy D, Surma S, Mizia-Stec K, Wiecek A
J Clin Med. 2023; 12(6).
PMID: 36983117
PMC: 10052744.
DOI: 10.3390/jcm12062114.
Targeting Adiponectin in Breast Cancer.
Nehme R, Diab-Assaf M, Decombat C, Delort L, Caldefie-Chezet F
Biomedicines. 2022; 10(11).
PMID: 36428526
PMC: 9687473.
DOI: 10.3390/biomedicines10112958.
Empagliflozin Attenuates Obesity-Related Kidney Dysfunction and NLRP3 Inflammasome Activity Through the HO-1-Adiponectin Axis.
Ye T, Zhang J, Wu D, Shi J, Kuang Z, Ma Y
Front Endocrinol (Lausanne). 2022; 13:907984.
PMID: 35784553
PMC: 9248377.
DOI: 10.3389/fendo.2022.907984.
Serum concentrations of leptin and adiponectin in dogs with chronic kidney disease.
Choi D, Yun T, Lee D, Koo Y, Chae Y, Yang M
J Vet Intern Med. 2022; 36(4):1330-1340.
PMID: 35621133
PMC: 9308420.
DOI: 10.1111/jvim.16463.
Adiponectin inhibits the activation of lung fibroblasts and pulmonary fibrosis by regulating the nuclear factor kappa B (NF-κB) pathway.
Wang X, Yang J, Wu L, Tong C, Zhu Y, Cai W
Bioengineered. 2022; 13(4):10098-10110.
PMID: 35435119
PMC: 9162013.
DOI: 10.1080/21655979.2022.2063652.
Association of Serum Adipokines and Resting Energy Expenditure in Patients With Chronic Kidney Disease.
Abi N, Xu X, Yang Z, Ma T, Dong J
Front Nutr. 2022; 9:828341.
PMID: 35369060
PMC: 8965443.
DOI: 10.3389/fnut.2022.828341.